Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the same
US7939662B2 · kind B2 · utility
0Cited by
7References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 6, 2007 |
| Grant date | May 10, 2011 |
| Priority date | — |
| Expiry date | Aug 3, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to a new and useful amorphous form of ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride) and preparations thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.